

Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer. Among its major competitors, Igenica is ranked in 7th place for NPS while MedImmune is 1st, and AVX Corporation is 2nd.Their current valuation is $330.00M